Breaking News
Investing Pro 0
Close

Pfizer Inc BDR (PFIZ34)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
51.49 +0.05    +0.10%
29/03 - Closed. Currency in BRL ( Disclaimer )
  • Volume: 4,024
  • Bid/Ask: 51.49 / 52.10
  • Day's Range: 51.45 - 51.93
Type:  Equity
Market:  Brazil
ISIN:  BRPFIZBDR006 
Pfizer Inc BDR 51.49 +0.05 +0.10%

PFIZ34 Income Statement

 
Assess the Pfizer Inc BDR income statement, view the company's financial performance across their assets and liabilities. Select to view either quarterly or annual data.
AnnualQuarterly
InvestingPro Advanced Income Statement
Period Ending: 2022
31/12
2022
02/10
2022
03/07
2022
03/04
Total Revenue 24290 22638 27742 25661
Revenue 24290 22638 27742 25661
Other Revenue, Total - - - -
Cost of Revenue, Total 9991 6037 8170 9954
Gross Profit 14299 16601 19572 15707
Total Operating Expenses 18591 12489 15003 15309
Selling/General/Admin. Expenses, Total 3854 2934 3196 2219
Research & Development 3615 2696 2815 2301
Depreciation / Amortization 374 355 - 343
Interest Expense (Income) - Net Operating -313 -311 -293 -322
Unusual Expense (Income) - - - -
Other Operating Expenses, Total 1070 778 1115 814
Operating Income 5699 10149 12739 10352
Interest Income (Expense), Net Non-Operating - - - -
Gain (Loss) on Sale of Assets 86 -119 -541 -698
Other, Net 383 1268 1832 1999
Net Income Before Taxes 5230 9000 11448 9051
Provision for Income Taxes 230 356 1570 1172
Net Income After Taxes 5000 8644 9878 7879
Minority Interest 256 259 261 261
Equity In Affiliates - - - -
U.S GAAP Adjustment - - - -
Net Income Before Extraordinary Items 4992 8629 9872 7873
Total Extraordinary Items 2 -21 34 -9
Net Income 4994 8608 9906 7864
Total Adjustments to Net Income -2 21 -34 9
Income Available to Common Excluding Extraordinary Items 4992 8629 9872 7873
Dilution Adjustment -12.11 -26.18 24.24 -24.46
Diluted Net Income 5006.11 8634.18 9881.76 7888.46
Diluted Weighted Average Shares 5743 5718 5712 5758
Diluted EPS Excluding Extraordinary Items 0.872 1.51 1.73 1.37
DPS - Common Stock Primary Issue 0.4 0.4 0.4 0.4
Diluted Normalized EPS 0.668 1.15 1.4 1.14
* In Millions of (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

PFIZ34 Comments

Write your thoughts about Pfizer Inc BDR
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email